Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole
Bi. Hirschowitz et Mm. Haber, Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole, ALIM PHARM, 15(1), 2001, pp. 87-103
Background: Helicobacter pylori is said to cause atrophy of the gastric cor
pus and enterochromaffin-like cell proliferation in gastro-oesophageal refl
ux disease (GERD) patients treated long-term with a proton pump inhibitor.
Aims: To determine the effect of H. pylori infection on gastritis, enteroch
romaffin-like cell density and hyperplasia, mucosal atrophy and serum gastr
in in patients with gastric hypersecretion (basal acid output gt; 15 mmol/h
) with either hypergastrinemia (Zollinger-Ellison syndrome) or normal gastr
in (non-Zollinger-Ellison syndrome) before and during long-term treatment w
ith lansoprazole.
Methods: Lansoprazole was individually titrated to reduce basal acid output
to < 5 mmol/h (< 1 mmol/h in post-surgical Zollinger-Ellison syndrome). Ga
stric corpus biopsies were obtained every 6 months before treatment and up
to 8 years later.
Results: H. pylori was present in corpus biopsies in approximate to 50%, ca
using active gastritis which resolved rapidly in 15 subjects after eliminat
ion of H. pylori. Patchy mild/moderate corpus atrophy was present at entry
in two and at the end in four out of 60 patients, one being H. pylori-posit
ive. Intestinal metaplasia (< 10%) was seen in six isolated biopsies (1% of
total). H. pylori did not affect serum gastrin, enterochromaffin-like cell
density or hyperplasia. Enterochromaffin-like cell density was twice as hi
gh in Zollinger-Ellison syndrome as in non-Zollinger-Ellison syndrome patie
nts (241 vs. 126 cells/mm(2), P < 0.001). Enterochromaffin-like cells remai
ned normal in the non-Zollinger-Ellison syndrome hypersecretors regardless
of H. pylori status.
Conclusions: Corpus enterochromaffin-like cell increases were related to se
rum gastrin elevation, but neither H. pylori nor long-term treatment with l
ansoprazole alone or together had any effect on enterochromaffin-like cell
density or hyperplasia. Corpus acute gastritis resulted from H. pylori infe
ction, but did not result in mucosal atrophy despite long-term proton pump
inhibitor treatment and promptly resolved with loss of H. pylori.